Targeting NF-κB in hematologic malignancies | Cell Death & Differentiation
Cells | Free Full-Text | Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets
NF-κB inhibitors in treatment and prevention of lung cancer - ScienceDirect
NF-κB inhibitors in treatment and prevention of lung cancer - ScienceDirect
The complexity of NF-κB signaling in inflammation and cancer | Molecular Cancer | Full Text
The role of nuclear factor kappa B in human labour in: Reproduction Volume 130 Issue 5 (2005)
A Computational Model of Lipopolysaccharide-Induced Nuclear Factor Kappa B Activation: A Key Signalling Pathway in Infection-Induced Preterm Labour | PLOS ONE
Nuclear factor kappa B activation appears weaker in schizophrenia patients with high brain cytokines than in non-schizophrenic controls with high brain cytokines | Journal of Neuroinflammation | Full Text
nuclear factor kappa B signaling pathwayRat Genome Database
NF-kB inhibitors and activators | Abcam
Activation of NF-KappaB by PKR
The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients | Inflammopharmacology
Cells | Free Full-Text | Challenges with Methods for Detecting and Studying the Transcription Factor Nuclear Factor Kappa B (NF-κB) in the Central Nervous System
NF-κB: blending metabolism, immunity, and inflammation: Trends in Immunology
The nuclear factor-kappa B pathway and response to treatment in breast cancer | Pharmacogenomics
NF-kB inhibitors and activators | Abcam
NF-κB - Wikipedia
IJMS | Free Full-Text | Small Molecule NF-κB Pathway Inhibitors in Clinic
Nuclear Factor kappa-B Pathway – Inflammation's Role in Obesity
Frontiers | NF-κB in neurodegenerative diseases: Recent evidence from human genetics
Cells | Free Full-Text | Cell-Type Targeted NF-kappaB Inhibition for the Treatment of Inflammatory Diseases
Carotenoid derivatives inhibit nuclear factor kappa B activity in bone and cancer cells by targeting key thiol groups - ScienceDirect
The Phosphorylation Status of Nuclear NF-ΚB Determines Its Association with CBP/p300 or HDAC-1: Molecular Cell
Nuclear factor‐kappa β as a therapeutic target for Alzheimer's disease - Jha - 2019 - Journal of Neurochemistry - Wiley Online Library
